Loading stock data...

Emmessar Biotech & Nutrition Limited

BSE: EMMESSA

BSE
25.25 -1.72 (-6.38%)

Prev Close

26.97

Open Price

27.84

Volume

1,172

Today Low / High

25.01 / 27.84

52 WK Low / High

24.29 / 42.9

Range

24 - 27

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 25.25, reflecting a change of -1.72 (-6.37746%). The expected target range on the BSE is 24 - 27. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

17 Feb 27.40 -0.77%
16 Feb 25.66 6.78%
13 Feb 27.68 -0.22%
12 Feb 28.80 -8.44%
11 Feb 27.06 2.73%
10 Feb 27.06 0.48%
09 Feb 29.98 -7.40%
06 Feb 32.60 -15.95%
05 Feb 28.39 -3.38%
04 Feb 26.01 7.00%
03 Feb 24.34 9.37%
02 Feb 26.70 -0.11%
01 Feb 26.99 -1.22%
30 Jan 26.24 -3.20%
29 Jan 27.79 -6.48%
28 Jan 28.00 -6.93%

Emmessar Biotech & Nutrition Limited Graph

Emmessar Biotech & Nutrition Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Emmessar Biotech & Nutrition Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 25.25, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 25.25 25.50 22.95 - 28.05
25.76 20.60 - 30.91
26.01 18.21 - 33.81
Bearish Scenario 25.25 25.00 22.50 - 27.50
24.75 19.80 - 29.69
24.49 17.14 - 31.84

Overview of Emmessar Biotech & Nutrition Limited

ISIN

INE634B01016

Industry

Medical - Pharmaceuticals

Vol.Avg

1,338

Market Cap

135,843,959

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

2.68

DCF

25

Financial Ratios Every Investor Needs

Stock Rating Details for EMMESSA

Metric Value Recommendation
Overall Rating B- Neutral
DCF Score 4 Buy
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.61 Cr 0.18 Cr 0.43 Cr 0.7024 0.00 Cr 0.94 Cr -1.05 Cr 0.32 Cr 0.61 1.06 Cr 0.5174
2024-03-31 0.56 Cr 1.30 Cr -0.74 Cr -1.3392 0.00 Cr 0.14 Cr -1.18 Cr 0.75 Cr 1.50 -1.08 Cr 1.3504
2023-03-31 1.02 Cr 0.40 Cr 0.62 Cr 0.6077 0.00 Cr 0.10 Cr -0.77 Cr 0.50 Cr 1.01 1.06 Cr 0.4943
2022-03-31 0.36 Cr 0.13 Cr 0.24 Cr 0.6558 0.00 Cr 0.10 Cr 0.84 Cr 0.48 Cr 0.95 1.02 Cr 1.3028
2021-03-31 6.99 Cr 3.53 Cr 3.46 Cr 0.4947 0.00 Cr 0.06 Cr 0.79 Cr 1.45 Cr 2.90 0.85 Cr 0.2074

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 6.87 Cr 9.22 Cr 1.51 Cr 7.7080 Cr 0.00 Cr -6.87 Cr 0.12 Cr 1.22 Cr 0.00 Cr 0.57 Cr 0.59 Cr 0.4725 Cr
2024-03-31 0.01 Cr 8.74 Cr 1.34 Cr 7.4024 Cr 0.11 Cr 0.10 Cr 0.09 Cr 1.31 Cr 0.00 Cr 0.00 Cr 0.60 Cr 0.5039 Cr
2023-03-31 0.01 Cr 7.94 Cr 1.28 Cr 6.6646 Cr 0.08 Cr 0.07 Cr 0.14 Cr 1.40 Cr 0.00 Cr 0.61 Cr 0.61 Cr 0.4195 Cr
2022-03-31 0.18 Cr 7.21 Cr 1.04 Cr 6.1689 Cr 0.00 Cr -0.18 Cr 0.07 Cr 1.45 Cr 0.01 Cr 0.61 Cr 0.62 Cr 0.3301 Cr
2021-03-31 0.53 Cr 7.81 Cr 2.11 Cr 5.7008 Cr 0.00 Cr -0.53 Cr 0.07 Cr 1.23 Cr 0.01 Cr 0.00 Cr 0.63 Cr 1.4025 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.2238 Cr -0.2298 Cr 0.0035 Cr 0.2238 Cr -0.0024 Cr 0.0105 Cr 0.0000 Cr 0.3161 Cr -0.1171 Cr 0.0000 Cr -0.0346 Cr
2024-03-31 0.6446 Cr -0.6435 Cr 0.0326 Cr 0.6446 Cr 0.0011 Cr 0.0129 Cr 0.0000 Cr 0.8126 Cr 0.0326 Cr 0.0000 Cr 0.0471 Cr
2023-03-31 0.3762 Cr -0.5463 Cr 0.0000 Cr 0.3499 Cr -0.1701 Cr 0.0118 Cr -0.0263 Cr 0.9669 Cr 0.0000 Cr 0.0000 Cr -0.0680 Cr
2022-03-31 2.2698 Cr -2.6144 Cr 0.0000 Cr 1.9642 Cr -0.3445 Cr 0.1819 Cr -0.3056 Cr 0.9315 Cr 0.0000 Cr 0.0000 Cr -0.0009 Cr
2021-03-31 0.4679 Cr 0.0082 Cr 0.0000 Cr 0.4661 Cr 0.4760 Cr 0.5264 Cr -0.0018 Cr 2.2545 Cr 0.0000 Cr 0.0000 Cr 1.0818 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 0.09 Cr 0.29 Cr -0.20 Cr -2.1701 -0.40 Cr 0.11 Cr 0.23 0.17 Cr 1.2432
2025-06-30 0.09 Cr 0.03 Cr 0.06 Cr 0.6659 -0.30 Cr 0.17 Cr 0.34 0.26 Cr 1.8448
2025-03-31 0.10 Cr 0.27 Cr -0.18 Cr -1.8307 -0.35 Cr -0.07 Cr -0.16 0.28 Cr -0.7168
2024-12-31 0.10 Cr 0.03 Cr 0.06 Cr 0.6656 -0.30 Cr 0.02 Cr 0.03 -0.28 Cr 0.1792
2024-09-30 0.34 Cr 0.13 Cr 0.21 Cr 0.6246 -0.10 Cr 0.28 Cr 0.56 -0.08 Cr 0.8197

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.01 Cr 7.19 Cr 7.20 Cr 0.05 Cr 0.11 Cr 7.74 Cr 1.18 Cr 9.52 Cr 1.52 Cr
2025-06-30 0.00 Cr 0.00 Cr 6.88 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -7.71 Cr
2025-03-31 6.87 Cr 6.87 Cr 6.88 Cr 0.05 Cr 0.12 Cr 7.41 Cr 1.22 Cr 9.22 Cr 1.51 Cr
2024-12-31 0.00 Cr 0.00 Cr 6.65 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -7.77 Cr
2024-09-30 0.11 Cr 6.77 Cr 6.89 Cr 0.10 Cr 0.11 Cr 7.42 Cr 1.26 Cr 9.29 Cr 1.52 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -0.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹835.05 ₹100,208,823,304.00 ₹147,497.00

Key Executives

Deputy General Manager
Ignatius J. Pereira

Gender: male

Year Born:

Chief Financial Officer, Executive Director & Internal Auditor
Jeyavel Balaiah Nadar

Gender: male

Year Born: 1960

Founder, Chief Executive Officer, MD & Executive Chairman
Mathurakavi Srinivasa Raghavan Ayyangar

Gender: male

Year Born: 1948

Company Secretary & Compliance Officer
Priyanka Omprakash Sharma

Gender: female

Year Born:

FAQs about Emmessar Biotech & Nutrition Limited

Who is the CEO of the company?

The CEO is Mathurakavi Srinivasa Raghavan Ayyangar.

What is the current market price of the stock?

The current price is ₹27.19.

What is the 52-week price range?

The range is ₹24.29-42.9.

What is the market capitalization of the company?

The market capitalization is ₹13.58 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 57.64.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Emmessar Biotech & Nutrition Limited (ISIN: INE634B01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹13.58 crores and an average daily volume of 1,338 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.